Previous Close | 9,100.00 |
Open | 9,200.00 |
Bid | 9,160.00 x N/A |
Ask | 9,164.00 x N/A |
Day's Range | 9,156.00 - 9,240.00 |
52 Week Range | 7,784.00 - 9,696.00 |
Volume | |
Avg. Volume | 1,923,480 |
Market Cap | 49.072B |
Beta (5Y Monthly) | 0.33 |
PE Ratio (TTM) | 66.39 |
EPS (TTM) | 1.38 |
Earnings Date | Feb 29, 2024 |
Forward Dividend & Yield | 1.15 (1.26%) |
Ex-Dividend Date | Apr 18, 2024 |
1y Target Est | 10,584.30 |
Junior stock exchange has lost 70 companies in past 12 months as UK market’s status faces scrutiny
AstraZeneca has suffered an investor backlash over a £19m pay award for its chief executive, in a vote that will deepen concerns of an exodus of UK companies to the US.
Shell's CEO has expressed dissatisfaction with the London Stock Exchange's valuation, indicating the possibility of exploring other options, including the abandonment of its London listing.